Acute Lymphoid Leukemia PB CD19+ B Cells (Newly Diagnosed/Untreated) from ACCEGEN BIOTECH
Search, find, compare suppliers for Acute Lymphoid Leukemia PB CD19+ B Cells (Newly Diagnosed/Untreated) products.
| Edit | |
|---|---|
| Product Name | Acute Lymphoid Leukemia PB CD19+ B Cells (Newly Diagnosed/Untreated) |
| Description | Acute Lymphoid Leukemia-PB-CD19 B cells are positively isolated from adult Acute Lymphoid Leukemia peripheral blood Mononuclear Cells, using a direct immunomagnetic CD19 MicroBead labeling system. Acute Lymphoid Leukemia-PB-CD19 B cells are available in the newly diagnosed and relapsed/refractory stages. |
| Size | 1 vial |
| Concentration | n/a |
| Applications | For research use only |
| Other Names | n/a |
| Gene, Accession, CAS # | n/a |
| Catalog # | ABC-TC3008 |
| Price | $980-$2980 |
| Order / More Info | Acute Lymphoid Leukemia PB CD19+ B Cells (Newly Diagnosed/Untreated) from ACCEGEN BIOTECH |
| Product Specific References | n/a |
ACCEGEN BIOTECH
ACCEGEN BIOTECH
277 Fairfield Road
Fairfield NJ 07004
P: +1-862-686-2696
F: +1-323-978-5598
inquiry@accegen.com
http://www.accegen.com
Profile of ACCEGEN BIOTECH